Insider

Cigna Group

CI Health Care · 3 analyses · 12 expectations tracked

Cigna reported $73.7B in revenue (+5.6% YoY), compared with a +7.2% median across covered Health Care peers. Insider tracks 12 open management expectations for this company.

What changed

Company history

October 2026

Cigna Group: 12 recorded developments from 3 official sources in 2026-10.

  • 2026-09-30: On September 30, 2026, The Cigna Group issued a press release noting that the Company will host its Investor Day, both in person and virtually, beginning at approximately 8:30 a.m. Eastern Time. Source
  • 2026-09-30: Deliver core growth: Build on the strong foundation of a deliberately shaped portfolio — including Cigna Healthcare and Evernorth’s Specialty & Care Services and Pharmacy Benefit Services — to drive growth Source
  • 2026-09-30: The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. Source
  • 2026-09-30: The Investor Day presentations are expected to begin on September 30, 2026 at approximately 8:30 a.m. Eastern Time and conclude by 12:30 p.m. Eastern Time. Source
  • 2026-09-30: Adjusted revenues is used by the Company’s management because it facilitates analysis of trends in underlying revenue, defined as total revenues excluding special items and the Company’s share of certain investment results of its joint ventures reported in the Cigna Healthcare segment us Source
  • 2026-09-30: Adjusted revenues is not determined in accordance with GAAP and should not be viewed as a substitute for the most directly comparable GAAP measure, total revenues. Source
  • 2026-09-30: Changes in percentages may be expressed in basis points. Source
  • 2026-09-30: The Company’s outlook excludes the potential effects of any business combinations that may occur after the date of this Report. Source
  • 2026-09-30: The share repurchase program may be affected through open market purchases in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended, including through Rule 10b5-1 trading plans, or privately negotiated transactions. Source
  • 2026-09-30: The program may be suspended or discontinued at any time. Source
  • 2026-10-09: Donna F. Zarcone informed the Board of Directors of The Cigna Group that she will retire from the Board effective December 31, 2026. Source
  • 2026-10-09: Donna F. Zarcone's retirement is not the result of any disagreement with the Company. Source

Monthly records are drafted by AI from each month’s checked filings and official sources (in English, as extracted), with every line linked to its source; storylines group related developments across analyses using vector embeddings (Amazon Titan Text Embeddings V2). Provisional context, not investment advice.

Key figures

From the 10-Q for the period ended September 30, 2026, filed November 5, 2026. SEC

LatestEarlierChange
Revenue quarter$73.7B$69.7B+5.6%
Operating income quarter$2.4B$2.6B-7.1%
Net income quarter$1.4B$1.9B-22.8%
Diluted EPS quarter$5.47$6.98-21.6%
Dividends per share quarter$1.56$1.51+3.3%
Operating cash flow year to date$3.3B$3.5B-5.0%
Cash and cash equivalents balance$6.2B$7.7B-19.4%

Next results expected around February 4, 2027 (estimate: the quarter ending about December 30, 2026 plus the 36 days the last report took). The company announces the actual date.

As the company tagged them in its filing (SEC XBRL). Quarter and year figures are compared with the same period a year earlier, balances with the previous balance sheet. Download CSV

Revenue by quarter, $B

65.6Q4 '24*3.3%65.5Q1 '253%67.2Q2 '253.4%69.7Q3 '253.7%72.5Q4 '25*3.2%68.5Q1 '263.4%71.7Q2 '263.7%73.7Q3 '263.3%
Bottom row: operating margin (operating income divided by revenue). Q4 = fiscal year minus the three quarters reported on their own. Revenue as the company tagged it in its SEC filings (XBRL). Guidance is the company's own, not our forecast.

Sector peers

How this company compares with 36 covered companies in Health Care (median revenue change +7.2% YoY), from archived SEC XBRL filings.

CompanyLatest revenueRevenue YoYOperating margin
Cigna Group CI$73.7B+5.6%3.3%
Unitedhealth Group Inc UNH$113B-0.4%5.8%
Mckesson Corp MCK$111B+7.6%1.4%
CVS Health Corp CVS$108B+5.4%3.3%
Cardinal Health Inc CAH$67.5B+5.5%1.1%
Elevance Health, Inc. ELV$51.4B+1.4%2.5%
Johnson & Johnson JNJ$25.4B+5.9%—

Latest reported period per company from SEC CompanyFacts (XBRL). Fiscal calendars differ across companies.

Expectations and reality

Open

  • Increasing 2026 outlook for adjusted income from operations to at least $30.60 per share.

    Said November 5, 2026 · Period named: 2026 · Source · Our article

    Not yet checked against later reports.

  • The Cigna Group's outlook for full year 2026 consolidated adjusted income from operations is at least $30.60 per share.

    Said November 5, 2026 · Period named: full year 2026 · Source · Our article

    Not yet checked against later reports.

  • The Company plans to exit the Individual and Family Plans medical business as of January 1, 2027.

    Said November 5, 2026 · Period named: January 1, 2027 · Source · Our article

    Not yet checked against later reports.

  • The company's outlook includes the potential effects of expected future share repurchases and anticipated 2026 dividends.

    Said November 5, 2026 · Period named: 2026 · Source · Our article

    Not yet checked against later reports.

  • Company officials expect to reaffirm consolidated adjusted earnings per share of at least $30.45 for full year 2026.

    Said September 30, 2026 · Period named: full year 2026 · Source · Our article

    AI assessment, provisional no new evidence in later reports yet (as of November 12, 2026) · Later article

  • Company officials expect to reaffirm Evernorth Health Services adjusted income from operations of at least $6.9 billion for full year 2026.

    Said September 30, 2026 · Period named: full year 2026 · Source · Our article

    Not yet checked against later reports.

Show all (12)
  • The Cigna Group provides 2026 – 2030 financial targets: 10-14% Adjusted EPS CAGR; ~$50 billion in cumulative operating cash flow

    Said September 30, 2026 · Period named: 2026 – 2030 · Source · Our article

    Not yet checked against later reports.

  • Company officials expect to provide a long-term average annual adjusted EPS growth target of 10-14%.

    Said September 30, 2026 · Source · Our article

    Not yet checked against later reports.

  • Company officials expect to reaffirm consolidated adjusted revenues of approximately $280 billion for full year 2026.

    Said September 30, 2026 · Period named: full year 2026 · Source · Our article

    AI assessment, provisional no new evidence in later reports yet (as of November 12, 2026) · Later article

  • The Cigna Group’s outlook includes the potential effects of expected future share repurchases and anticipated 2026 dividends.

    Said September 30, 2026 · Period named: 2026 · Source · Our article

    Not yet checked against later reports.

  • Company officials expect to reaffirm Cigna Healthcare medical care ratio of 83.7% to 84.7% for full year 2026.

    Said September 30, 2026 · Period named: full year 2026 · Source · Our article

    Not yet checked against later reports.

  • Company officials expect to reaffirm Cigna Healthcare adjusted income from operations of at least $4.55 billion for full year 2026.

    Said September 30, 2026 · Period named: full year 2026 · Source · Our article

    Not yet checked against later reports.

What management said to expect (targets, plans, forecasts) in the company's own documents (in English, as extracted), with the date and the period it named. Assessments are written by AI from the company's later reports: provisional, not checked by an editor, and a consistent later report is not proof. An editor's decision replaces them.

Governance events

Filings about how the company is run: auditor changes, restatements, leadership changes, late filings, delistings, Schedule 13D stakes and SEC comment letters, newest first.

DateEventFiling
October 9, 2026Director or officer departure or appointment (8-K item 5.02)8-K

As filed with the SEC, read by code. A comment letter is part of the SEC staff’s routine review and does not by itself mean a problem; item 5.02 covers appointments as well as departures; Form 25 may concern a bond or another class of securities.

Large funds (13F)

FundSharesValueChange in sharesQuarter
BlackRock24,113,368$6,554,736,821+2.9%Q3 2026
State Street12,959,550$3,522,794,477+2.2%Q3 2026
Fidelity (FMR)6,813,015$1,851,982,015-15.0%Q3 2026
Geode Capital Management6,817,241$1,845,423,071+8.8%Q3 2026
Norges Bank (Norway's sovereign fund)3,562,699$982,164,860—Q2 2026
Two Sigma Investments1,291,082$350,954,820-28.8%Q3 2026
D. E. Shaw & Co.1,073,592$291,834,513+283.2%Q3 2026
Citadel Advisors638,382$173,531,379+98.6%Q3 2026
Renaissance Technologies330,819$89,926,529-4.2%Q3 2026
Capital Research Global Investors150,511$40,913,450-87.8%Q3 2026
Bridgewater Associates105,182$28,591,623+19.7%Q3 2026
Millennium Management40,573$11,028,959-91.1%Q3 2026
T. Rowe Price1,244,690$338,345-1.6%Q3 2026
Wellington Management863$234,590-98.6%Q3 2026

From the quarterly 13F-HR holdings reports of the large funds we follow, as filed. Funds file up to 45 days after the quarter ends, so positions may have changed since. Change: against the same fund's previous quarter. Not a recommendation.